Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
Veterans Affairs Medical Center - Minneapolis
mi
from
Minneapolis, MN
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Veterans Affairs Medical Center - Minneapolis
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
Veterans Affairs Medical Center - Columbia (Truman Memorial)
mi
from
Columbia, MO
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Veterans Affairs Medical Center - Columbia (Truman Memorial)
mi
from
Columbia, MO
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
Ellis Fischel Cancer Center - Columbia
mi
from
Columbia, MO
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Ellis Fischel Cancer Center - Columbia
mi
from
Columbia, MO
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
University of Missouri
mi
from
Columbia, MO
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
University of Missouri
mi
from
Columbia, MO
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
CCOP - Southern Nevada Cancer Research Foundation
mi
from
Las Vegas, NV
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
CCOP - Southern Nevada Cancer Research Foundation
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
Norris Cotton Cancer Center
mi
from
Lebanon, NH
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Norris Cotton Cancer Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
Veterans Affairs Medical Center - Buffalo
mi
from
Buffalo, NY
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Veterans Affairs Medical Center - Buffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
CCOP - North Shore University Hospital
mi
from
Manhasset, NY
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
CCOP - North Shore University Hospital
mi
from
Manhasset, NY
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
North Shore University Hospital
mi
from
Manhasset, NY
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
North Shore University Hospital
mi
from
Manhasset, NY
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
The New York Presbyterian Hospital - Cornell Campus
mi
from
New York, NY
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
The New York Presbyterian Hospital - Cornell Campus
mi
from
New York, NY
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
Mount Sinai Medical Center, NY
mi
from
New York, NY
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Mount Sinai Medical Center, NY
mi
from
New York, NY
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C.
mi
from
Syracuse, NY
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C.
mi
from
Syracuse, NY
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
State University of New York Upstate Medical University
mi
from
Syracuse, NY
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
State University of New York Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
Veterans Affairs Medical Center - Syracuse
mi
from
Syracuse, NY
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Veterans Affairs Medical Center - Syracuse
mi
from
Syracuse, NY
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
Lineberger Comprehensive Cancer Center, UNC
mi
from
Chapel Hill, NC
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Lineberger Comprehensive Cancer Center, UNC
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
Veterans Affairs Medical Center - Durham
mi
from
Durham, NC
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Veterans Affairs Medical Center - Durham
mi
from
Durham, NC
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
Duke Comprehensive Cancer Center
mi
from
Durham, NC
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Duke Comprehensive Cancer Center
mi
from
Durham, NC
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
CCOP - Southeast Cancer Control Consortium
mi
from
Winston-Salem, NC
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
CCOP - Southeast Cancer Control Consortium
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
Comprehensive Cancer Center of Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Comprehensive Cancer Center of Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
Arthur G. James Cancer Hospital - Ohio State University
mi
from
Columbus, OH
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Arthur G. James Cancer Hospital - Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
Rhode Island Hospital
mi
from
Providence, RI
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
Medical University of South Carolina
mi
from
Charleston, SC
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
University of Tennessee, Memphis Cancer Center
mi
from
Memphis, TN
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
University of Tennessee, Memphis Cancer Center
mi
from
Memphis, TN
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
Veterans Affairs Medical Center - Memphis
mi
from
Memphis, TN
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Veterans Affairs Medical Center - Memphis
mi
from
Memphis, TN
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
Veterans Affairs Medical Center - White River Junction
mi
from
White River Junction, VT
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Veterans Affairs Medical Center - White River Junction
mi
from
White River Junction, VT
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
Veterans Affairs Medical Center - Richmond
mi
from
Richmond, VA
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Veterans Affairs Medical Center - Richmond
mi
from
Richmond, VA
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
MBCCOP - Massey Cancer Center
mi
from
Richmond, VA
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
MBCCOP - Massey Cancer Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated:  7/11/2016
Memorial Sloan Kettering at Basking Ridge
mi
from
Basking Ridge, NJ
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated: 7/11/2016
Memorial Sloan Kettering at Basking Ridge
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated:  7/11/2016
Memorial Sloan-Kettering Cancer Center at Commack
mi
from
Commack, NY
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated: 7/11/2016
Memorial Sloan-Kettering Cancer Center at Commack
mi
from
Commack, NY
Click here to add this to my saved trials
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated:  7/11/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated: 7/11/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated:  7/11/2016
Memorial Sloan Kettering Cancer Center at Mercy Medical Center
mi
from
Rockville Centre, NY
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated: 7/11/2016
Memorial Sloan Kettering Cancer Center at Mercy Medical Center
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated:  7/11/2016
Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center
mi
from
Sleepy Hollow, NY
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated: 7/11/2016
Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center
mi
from
Sleepy Hollow, NY
Click here to add this to my saved trials
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
New Haven, CT
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Bronx, NY
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
New York, NY
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
New York, NY
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Rochester, NY
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Cleveland, OH
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
mi
from
Seattle, WA
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated:  7/12/2016
mi
from
Camperdown,
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated: 7/12/2016
mi
from
Camperdown,
Click here to add this to my saved trials
Pain Management Smartphone Application for Patients With Stage III-IV Head and Neck Cancer Undergoing Radiation Therapy
A Pilot Study for a Pain Management Smartphone Application for Patients Undergoing Radiation Therapy for Locally Advanced Head and Neck Cancer
Status: Enrolling
Updated:  7/12/2016
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Pain Management Smartphone Application for Patients With Stage III-IV Head and Neck Cancer Undergoing Radiation Therapy
A Pilot Study for a Pain Management Smartphone Application for Patients Undergoing Radiation Therapy for Locally Advanced Head and Neck Cancer
Status: Enrolling
Updated: 7/12/2016
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
PHASE III STUDY OF HEPATIC ARTERY FLOXURIDINE (FUDR), LEUCOVORIN (LV), AND DEXAMETHASONE (DEX) VERSUS SYSTEMIC 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) AS TREATMENT FOR HEPATIC METASTASES FROM COLORECTAL CANCER
Status: Enrolling
Updated:  7/12/2016
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
PHASE III STUDY OF HEPATIC ARTERY FLOXURIDINE (FUDR), LEUCOVORIN (LV), AND DEXAMETHASONE (DEX) VERSUS SYSTEMIC 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) AS TREATMENT FOR HEPATIC METASTASES FROM COLORECTAL CANCER
Status: Enrolling
Updated: 7/12/2016
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
PHASE III STUDY OF HEPATIC ARTERY FLOXURIDINE (FUDR), LEUCOVORIN (LV), AND DEXAMETHASONE (DEX) VERSUS SYSTEMIC 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) AS TREATMENT FOR HEPATIC METASTASES FROM COLORECTAL CANCER
Status: Enrolling
Updated:  7/12/2016
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
PHASE III STUDY OF HEPATIC ARTERY FLOXURIDINE (FUDR), LEUCOVORIN (LV), AND DEXAMETHASONE (DEX) VERSUS SYSTEMIC 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) AS TREATMENT FOR HEPATIC METASTASES FROM COLORECTAL CANCER
Status: Enrolling
Updated: 7/12/2016
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
PHASE III STUDY OF HEPATIC ARTERY FLOXURIDINE (FUDR), LEUCOVORIN (LV), AND DEXAMETHASONE (DEX) VERSUS SYSTEMIC 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) AS TREATMENT FOR HEPATIC METASTASES FROM COLORECTAL CANCER
Status: Enrolling
Updated:  7/12/2016
John Stoddard Cancer Center at Iowa Methodist Medical Center
mi
from
Des Moines, IA
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
PHASE III STUDY OF HEPATIC ARTERY FLOXURIDINE (FUDR), LEUCOVORIN (LV), AND DEXAMETHASONE (DEX) VERSUS SYSTEMIC 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) AS TREATMENT FOR HEPATIC METASTASES FROM COLORECTAL CANCER
Status: Enrolling
Updated: 7/12/2016
John Stoddard Cancer Center at Iowa Methodist Medical Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
PHASE III STUDY OF HEPATIC ARTERY FLOXURIDINE (FUDR), LEUCOVORIN (LV), AND DEXAMETHASONE (DEX) VERSUS SYSTEMIC 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) AS TREATMENT FOR HEPATIC METASTASES FROM COLORECTAL CANCER
Status: Enrolling
Updated:  7/12/2016
Mercy Cancer Center at Mercy Medical Center - Des Moines
mi
from
Des Moines, IA
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
PHASE III STUDY OF HEPATIC ARTERY FLOXURIDINE (FUDR), LEUCOVORIN (LV), AND DEXAMETHASONE (DEX) VERSUS SYSTEMIC 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) AS TREATMENT FOR HEPATIC METASTASES FROM COLORECTAL CANCER
Status: Enrolling
Updated: 7/12/2016
Mercy Cancer Center at Mercy Medical Center - Des Moines
mi
from
Des Moines, IA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
PHASE III STUDY OF HEPATIC ARTERY FLOXURIDINE (FUDR), LEUCOVORIN (LV), AND DEXAMETHASONE (DEX) VERSUS SYSTEMIC 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) AS TREATMENT FOR HEPATIC METASTASES FROM COLORECTAL CANCER
Status: Enrolling
Updated:  7/12/2016
Iowa Lutheran Hospital
mi
from
Des Moines, IA
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
PHASE III STUDY OF HEPATIC ARTERY FLOXURIDINE (FUDR), LEUCOVORIN (LV), AND DEXAMETHASONE (DEX) VERSUS SYSTEMIC 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) AS TREATMENT FOR HEPATIC METASTASES FROM COLORECTAL CANCER
Status: Enrolling
Updated: 7/12/2016
Iowa Lutheran Hospital
mi
from
Des Moines, IA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
PHASE III STUDY OF HEPATIC ARTERY FLOXURIDINE (FUDR), LEUCOVORIN (LV), AND DEXAMETHASONE (DEX) VERSUS SYSTEMIC 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) AS TREATMENT FOR HEPATIC METASTASES FROM COLORECTAL CANCER
Status: Enrolling
Updated:  7/12/2016
Midlands Cancer Center at Midlands Community Hospital
mi
from
Papillion, NE
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
PHASE III STUDY OF HEPATIC ARTERY FLOXURIDINE (FUDR), LEUCOVORIN (LV), AND DEXAMETHASONE (DEX) VERSUS SYSTEMIC 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) AS TREATMENT FOR HEPATIC METASTASES FROM COLORECTAL CANCER
Status: Enrolling
Updated: 7/12/2016
Midlands Cancer Center at Midlands Community Hospital
mi
from
Papillion, NE
Click here to add this to my saved trials